Improving bone healing after oral cancer treatment using microRNA
Oral and Craniofacial Bone Regeneration using MicroRNA Modulation
This study is looking at how special tiny molecules called microRNAs can help improve bone healing for patients with oral cancer who need surgery to fix their bones after tumor removal, especially when standard treatments like radiation make healing harder.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-11116282 on NIH RePORTER |
What this research studies
This research focuses on enhancing bone regeneration in patients with oral squamous cell carcinoma (OSCC) who require reconstructive surgery after tumor removal. It investigates the use of microRNAs, which are small molecules that can influence bone metabolism and cancer progression, to improve healing outcomes. The study aims to address complications arising from standard treatments, such as radiotherapy, which can hinder bone healing. By applying plasmid DNA that encodes specific microRNAs, the research seeks to promote better bone formation and integration of grafts in affected patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with advanced oral squamous cell carcinoma who require reconstructive surgery due to bone invasion.
Not a fit: Patients with early-stage oral cancer or those not requiring surgical intervention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healing and reduced complications for patients undergoing surgery for oral cancer.
How similar studies have performed: Previous studies have shown promise in using microRNAs for bone regeneration, indicating potential for success in this novel approach.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Hong, Liu — University of Iowa
- Study coordinator: Hong, Liu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.